These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 116778)

  • 1. Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials.
    Penta JS; Rozencweig M; Guarino AM; Muggia FM
    Cancer Chemother Pharmacol; 1979; 3(2):97-101. PubMed ID: 116778
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA; Slavik M; Carter SK
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal toxicology for early clinical trials with anticancer agents.
    Rozencweig M; Von Hoff DD; Staquet MJ; Schein PS; Penta JS; Goldin A; Muggia FM; Freireich EJ; DeVita VT
    Cancer Clin Trials; 1981; 4(1):21-8. PubMed ID: 6783332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic trials with cytostatics (author's transl)].
    Klein HO
    Blut; 1977 Aug; 35(2):97-102. PubMed ID: 409446
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical toxicology of anticancer agents.
    Schein PS
    Cancer Res; 1977 Jun; 37(6):1934-7. PubMed ID: 404039
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicology of environmental agents: a blend of applied and basic research.
    Dixon RL
    Environ Health Perspect; 1972 Oct; 2():103-16. PubMed ID: 4628852
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.
    Foster BJ; Clagett-Carr K; Hoth D; Leyland-Jones B
    Cancer Treat Rep; 1986 Mar; 70(3):383-9. PubMed ID: 3082512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Homan ER; Dixon RL; Guarino AM
    Cancer Chemother Rep 3; 1973 Jan; 4(1):1-39. PubMed ID: 4634117
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytosine arabinoside (NSC-63878)--clinical brochure.
    Livingston RB; Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man.
    Homan ER
    Cancer Chemother Rep 3; 1972 May; 3(1):13-9. PubMed ID: 4626119
    [No Abstract]   [Full Text] [Related]  

  • 15. Dibromodulcitol (NSC-104800)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):165-77. PubMed ID: 4989813
    [No Abstract]   [Full Text] [Related]  

  • 16. Working session report: laboratory of toxicology.
    Dixon RL
    Cancer Chemother Rep 3; 1972 May; 3(1):63-7. PubMed ID: 4626120
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance.
    Mirsalis JC; Schindler-Horvat J; Hill JR; Tomaszewski JE; Donohue SJ; Tyson CA
    Cancer Chemother Pharmacol; 1999; 44(5):395-402. PubMed ID: 10501913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):63-80. PubMed ID: 4989815
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation of preclinical toxicology to findings in early clinical trials.
    Grieshaber CK; Marsoni S
    Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.